Gemcitabine-induced chronic systemic capillary leak syndrome
- PMID: 28855215
- PMCID: PMC5589048
- DOI: 10.1136/bcr-2017-221068
Gemcitabine-induced chronic systemic capillary leak syndrome
Abstract
A 56-year-old woman presented with anasarca, hypoalbuminaemia and hypotension following cycle 3 day 1 of adjuvant gemcitabine for stage II pancreatic cancer. Due to the temporal nature of presentation, suspicion for gemcitabine-induced capillary leak syndrome was included in the differential diagnosis. Vascular endothelial growth factor levels were elevated at 707 pg/mL (reference range: 9-86 pg/mL). Corticosteroids were initiated, resulting in complete resolution of symptoms and hypotension. The patient suffered relapse of symptoms on discontinuation of steroids, further supporting chronic capillary leak syndrome.
Keywords: contraindications and precautions; pancreatic cancer; unwanted effects / adverse reactions.
© BMJ Publishing Group Ltd (unless otherwise stated in the text of the article) 2017. All rights reserved. No commercial use is permitted unless otherwise expressly granted.
Conflict of interest statement
Competing interests: None declared.
Similar articles
-
[Anasarca, a complication of chemotherapy with gemcitabine in two patients with pancreatic cancer].Gastroenterol Clin Biol. 2007 Dec;31(12):1143-5. doi: 10.1016/s0399-8320(07)78353-7. Gastroenterol Clin Biol. 2007. PMID: 18176375 French.
-
Gemcitabine-induced chronic systemic capillary leak syndrome: a life-threatening disease.Clin Oncol (R Coll Radiol). 2006 Feb;18(1):90-1. doi: 10.1016/j.clon.2005.09.003. Clin Oncol (R Coll Radiol). 2006. PMID: 16477934 No abstract available.
-
Cure of gemcitabine-induced systemic capillary leak syndrome without corticosteroids.J BUON. 2009 Oct-Dec;14(4):728-9. J BUON. 2009. PMID: 20148474 No abstract available.
-
[IMRD therapy for patients with metastatic pancreas cancer].Nihon Rinsho. 2006 Jan;64 Suppl 1:219-22. Nihon Rinsho. 2006. PMID: 16457254 Review. Japanese. No abstract available.
-
[A case of hemolytic uremic syndrome after adjuvant chemotherapy with gemcitabine in a patient with pancreatic cancer].Nihon Shokakibyo Gakkai Zasshi. 2010 Oct;107(10):1676-85. Nihon Shokakibyo Gakkai Zasshi. 2010. PMID: 20938119 Review. Japanese.
Cited by
-
Systemic capillary leak syndrome following granulocyte colony-stimulating factor therapy in a T-lymphoblastic leukemia/lymphoma patient: a case report.Memo. 2022;15(2):143-148. doi: 10.1007/s12254-021-00789-z. Epub 2022 Jan 21. Memo. 2022. PMID: 35096191 Free PMC article.
-
Systemic Capillary Leak Syndrome (SCLS) Presentation in Patients Receiving Anti-cancer Treatments.Cureus. 2023 Apr 30;15(4):e38335. doi: 10.7759/cureus.38335. eCollection 2023 Apr. Cureus. 2023. PMID: 37261188 Free PMC article. Review.
-
Anticancer Drug-Induced Capillary Leak Syndrome.Kidney Int Rep. 2022 Feb 25;7(5):945-953. doi: 10.1016/j.ekir.2022.02.014. eCollection 2022 May. Kidney Int Rep. 2022. PMID: 35570987 Free PMC article. Review.
-
Combinatorial Efficacy and Toxicity of an Engineered Toxin Body MT-3724 with Gemcitabine and Oxaliplatin in Relapsed or Refractory Diffuse Large B Cell Lymphoma.Cancer Invest. 2023 Jan 31:1-10. doi: 10.1080/07357907.2022.2162073. Online ahead of print. Cancer Invest. 2023. PMID: 36657101 Free PMC article.
-
Chronic idiopathic systemic capillary leak syndrome: a case report.Allergy Asthma Clin Immunol. 2019 May 28;15:34. doi: 10.1186/s13223-019-0347-0. eCollection 2019. Allergy Asthma Clin Immunol. 2019. PMID: 31160895 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical